MedTrace Logo

Brain-Computer Interface System for Training Memory and Attention in Elderly

NCT02228187 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-08-02

No results posted yet for this study

Summary

The primary objective is to examine the efficacy of 8-weeks of a locally developed brain-computer interface based system intervention for improving attention and memory in healthy elderly and those with age related cognitive decline. We hypothesize that elderly who have completed the training program will have significant improvement in their attention and memory compared to the controls, based on the Repeatable Battery for the Assessment of Neuropsychological Status.

Conditions

Interventions

DEVICE

Brain-Computer Interface

Brain-computer Interface (BCI) is a direct communication pathway between a human brain and an external device. It is a technology that enables people to interact with computers through their thoughts. Electroencephalography (EEG) is the best studied non-invasive interface facilitating such communication. The BCI system will take EEG recordings from the prefrontal cortex to determine the participants' state of attention with high specificity. The training program developed using this patented technology may be useful for individuals who experience difficulty with memory and sustaining their attention.

Sponsors & Collaborators

  • Agency for Science, Technology and Research

    collaborator OTHER

  • National University of Singapore

    collaborator OTHER

  • Singapore Clinical Research Institute

    collaborator OTHER

  • Singapore General Hospital

    collaborator OTHER

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Duke-NUS Graduate Medical School

    lead OTHER

Principal Investigators

  • Tih Shih Lee, MD, PhD · Duke-NUS Medical School, Duke University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02228187 on ClinicalTrials.gov